WHO ICTRP trial
Measurement of blood sugar levels after prednisolone
ACTRN12609000028202 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12609000028202 |
|---|---|
| Public title | Measurement of blood sugar levels after prednisolone |
| Scientific title | Assessment of the hyperglycaemic effect of high-dose prednisolone used for exacerbations in Chronic Obstructive Pulmonary Disease. |
| Primary sponsor | Repatriation General Hospital |
| Secondary sponsors | Department of Health |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease;Respiratory - Chronic obstructive pulmonary disease |
| Interventions | use of continuous glucose monitoring to better define the nature of prednisolone induced hyperglycaemia. Each patient will be monitored for up to 3 days and high dose prednisolone is defined as a single daily oral dose of 20mg or more… |
| Registration date | Jan 16, 2009 |
| Target size | 50 |
| Secondary IDs | nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: